Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
3999309 | Urologic Oncology: Seminars and Original Investigations | 2016 | 8 Pages |
Abstract
The use of a rectal spacer for conformal RT results in a marginal cost increase with a significant reduction in rectal toxicity assuming recently published 15 month rectal toxicity reduction is maintained over 10 years. For high-dose SBRT it was cost effective. Further studies would be necessary to validate the long-term benefits of rectal spacers.
Related Topics
Health Sciences
Medicine and Dentistry
Oncology
Authors
Ryan C. M.D., Varun M.D., Michael M.D., Ph.D., Yair M.D.,